{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-23-006823","form_type":"8-K","ticker":"TDOC","cik":"0001477449","company_name":"Teladoc Health, Inc.","filed_at":"2023-04-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.986837+00:00","generated_at":"2026-06-16T12:34:05.592542+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Teladoc Q1 revenue $629M (+11% YoY); net loss $0.42/sh; guides Q2 rev $635-660M","bullets":["Revenue $629.2M (+11% YoY); Integrated Care $350M (+5%), BetterHelp $279M (+21%).","Net loss $69.2M ($0.42/sh) vs $6.67B loss in Q1 2022 which included $6.6B goodwill impairment.","Adjusted EBITDA $52.8M (-3% YoY); Integrated Care segment adj. EBITDA +51% to $35.1M, BetterHelp -41% to $17.6M.","Q2 2023 guidance: rev $635-660M, adj. EBITDA $60-68M, net loss per share ($0.55)-($0.45).","Full year 2023 guidance: rev $2.575-2.675B, adj. EBITDA $285-325M, net loss per share ($1.70)-($1.25)."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-23-006823","json":"https://secwatch.observer/filing/0001558370-23-006823.json","markdown":"https://secwatch.observer/filing/0001558370-23-006823.md","text":"https://secwatch.observer/filing/0001558370-23-006823.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1477449/000155837023006823/0001558370-23-006823-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1477449/000155837023006823/tdoc-20230426x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T12:34:05.592542+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"22a96665ec646eb259a43e2c43c434ae7d25156d","claim":"Teladoc Health, Inc. reported first quarter ended March 31, 2023 results: revenue $629.2 million, net income Net loss of $69.2 million, EPS $0.42 per share. Guidance initiated.","evidence_excerpt":"● First quarter 2023 revenue grows 11% year-over-year to $629.2 million ● First quarter 2023 net loss of $69.2 million, or $0.42 per share ● First quarter adjusted EBITDA totaled $52.8 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1477449/000155837023006823/0001558370-23-006823-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2023"},{"label":"Revenue","value":"$629.2 million"},{"label":"Net income","value":"Net loss of $69.2 million"},{"label":"EPS","value":"$0.42 per share"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}